AC8 0.00% 4.0¢ auscann group holdings ltd

Ann: AusCann to Commence Cannabinoid Trial in Spinal Cord Injury, page-11

  1. 12,536 Posts.
    lightbulb Created with Sketch. 1779
    Cannabinoids are now on the radar for use in numerous markets.

    It will become a mainstream medicinal product used to provide pain relief for a variety of conditions within humans and animals

    AC8 is now restructured with a data base of knowledge/experience and new products that in good time will provide many multiples of the existing share price.

    Ignition will occur.
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.